From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease
(Current Pharmaceutical Design, 2011) reported that BPC-157 remains stable in human gastric juice for more than 24 hours, which is unusual for a peptide
Patients with alcohol use disorder may have unique safety considerations when using GLP-1 medications
HSA/FSA eligibility depends on individual plan rules, so prospective patients should check with their plan administrator before assuming reimbursement will apply
Market Dynamics Driver Rising Global Burden of Cardiometabolic Disorders One of the key drivers of the cardiometabolic therapeutics market is the increasing prevalence of lifestyle-related disorders such as obesity, type 2 diabetes, hypertension, and cardiovascular diseases
doi:10.22038/ijbms.2022.59627.13231 Abbood MS, Al-Adsani AM, Al-Bustan SA